Top Pharma Companies in India by Market Cap

BSE Sensex 74682.53 176.46 (-0.24%)

Filter

Top Pharma Companies in India as on Sep-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks

Filter

	Company Name	DeciZen	Market cap (Rs. Cr.)	CMP (Change %)	Latest P/E	Latest P/BV	5Y Sales Gr.(%)	5Y Profit Gr.(%)
1	3B Blackbio Dx Ltd.	Q V PT	1,139 Small Cap	1,400.65 (-0.50%)	21.76	4.31	27.29	40.23	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
2	Aarti Drugs Ltd.	Q V PT	3,941 Small Cap	435.50 (-0.01%)	20.79	2.49	3.55	-6.47	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
3	Aarti Pharmalabs Ltd.	Q V+ PT	7,443 Small Cap	901 (6.44%)	36.88	3.74	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
4	Abbott India Ltd.	Q V PT	57,954 Mid Cap	27,170 (0.76%)	35.48	11.07	9.96	17.33	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
5	Acutaas Chemicals Ltd.	Q V+ PT	28,149 Small Cap	3,314.50 (-3.15%)	72.55	16.24	31.50	70.35	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
6	Advanced Enzyme Technologies Ltd.	Q V PT	3,227 Small Cap	296 (0.70%)	41.06	4.55	9.82	13.51	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
7	Ajanta Pharma Ltd.	Q V+ PT	44,562 Mid Cap	3,504.80 (-0.85%)	38.92	9.09	13.54	10.92	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
8	Akums Drugs & Pharmaceuticals Ltd.	Q V+ PT	12,339 Small Cap	816.70 (-0.55%)	44.31	3.78	9.87	8.26	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
9	Alembic Pharmaceuticals Ltd.	Q V+ PT	16,623 Small Cap	843.05 (-0.86%)	24.1	2.86	6.37	-8.79	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
10	Alivus Life Sciences Ltd.	Q V+ PT	17,570 Small Cap	1,399 (-0.12%)	28.52	4.93	6.24	6.07	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
11	Alkem Laboratories Ltd.	Q V PT	65,780 Mid Cap	5,394.95 (0.84%)	29.65	4.47	10.66	8.92	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
12	Ambalal Sarabhai Enterprises Ltd.	Q V PT	310 Small Cap	39.24 (1.50%)	21.85	1.83	4.33	3.30	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
13	Amrutanjan Health Care Ltd.	Q V+ PT	1,427 Small Cap	501.20 (1.16%)	26.54	3.82	8.59	1.17	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
14	Anlon Healthcare Ltd.	Q V+ PT	1,219 Small Cap	29.04 (10.00%)	49.21	4.81	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
15	Anthem Biosciences Ltd.	Q V PT	52,619 Mid Cap	910 (-0.91%)	89.86	16.54	14.00	16.46	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
16	Anuh Pharma Ltd.	Q V PT	936 Small Cap	94.74 (1.34%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
17	Apollo Hospitals Enterprise Ltd.	Q V+ PT	1,26,103 Large Cap	8,912.15 (-0.31%)	81.82	12.46	14.92	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
18	Artemis Medicare Services Ltd.	Q V+ PT	5,358 Small Cap	343.50 (1.60%)	47.09	5.97	21.50	83.35	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
19	Aster DM Quality Care Ltd.	Q V+ PT	65,885 Mid Cap	756.40 (-0.01%)	206.91	15.59	-11.61	19.15	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
20	Astrazeneca Pharma India Ltd.	Q V PT	16,879 Small Cap	6,629 (-0.52%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
21	Aurobindo Pharma Ltd.	Q V+ PT	99,828 Mid Cap	1,701.70 (-0.90%)	38.11	4.21	-6.73	-4.90	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
22	Bajaj Healthcare Ltd.	Q V PT	1,108 Small Cap	338.75 (0.82%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
23	Biocon Ltd.	Q V PT	62,743 Mid Cap	392.55 (-0.62%)	658.88	2.35	2.96	-18.61	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
24	Bliss GVS Pharma Ltd.	Q V+ PT	7,235 Small Cap	687.75 (4.59%)	51.34	5.67	9.94	8.65	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
25	Blue Jet Healthcare Ltd.	Q V PT	10,887 Small Cap	585.70 (1.05%)	46.7	4.9	13.68	9.45	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
26	Caplin Point Laboratories Ltd.	Q V PT	20,887 Small Cap	2,803.25 (1.68%)	31.5	5.71	15.56	20.24	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
27	Cipla Ltd.	Q V PT	1,10,794 Large Cap	1,368.90 (-1.16%)	33.19	3.18	8.01	10.07	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
28	Cohance Lifesciences Ltd.	Q V+ PT	16,760 Small Cap	458.10 (-0.54%)	165.89	4.58	17.57	-18.37	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
29	Concord Biotech Ltd.	Q V PT	15,629 Small Cap	1,545 (-2.26%)	60.05	7.98	11.33	1.26	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
30	CORONA Remedies Ltd.	Q V+ PT	13,448 Small Cap	2,193 (-0.96%)	68.04	16.78	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
Prev 1 2 3 4 5 Next

Screens:

AlphaCases Top Rated Stocks Best Nifty Stocks Best Nifty Next Stocks Best Nifty 500 Stocks Best SmallCap Stocks Top BFSI Stocks

Pharma - Today's Top Gainers

Company Name	CMP	Price Change(%)
Anlon Healthcare	29.04	10%
Ind-Swift Labs.	406.75	6.60%
Aarti Pharmalabs	901	6.44%
Syncom Formulations	20.81	5.10%
Kilitch Drugs(India)	213.20	5%

Pharma - Today's Top Losers

Company Name	CMP	Price Change(%)
Kopran	272.95	-3.57%
Kwality Pharma	3,700	-3.57%
Guj. Kidney & Super	176.90	-3.41%
Acutaas Chemicals	3,314.50	-3.15%
Concord Biotech	1,545	-2.26%

News about Top Pharma Companies in India

Sep, 2026

Anlon Healthcare incorporates subsidiary in Nigeria

This subsidiary will provide access to 16 Western African Countries via its local entity

Sep, 2026

Cohance Lifesciences informs about update

Cohance Lifesciences has informed that the United States Food and Drug Administration (USFDA) inspected the Company’s API manufacturing facility at Jaggaiahpet, Andhra Pradesh, India (FEI No. 3005554260), from 14 September to 19 September 2026. The inspection concluded with the issuance of a Form FDA 483 containing five observations. The Company has initiated appropriate corrective and preventive actions (CAPA) and will submit its response within the stipulated timeline. The Company remains committed to quality and regulatory compliance.

The above information is a part of company’s filings submitted to BSE.

Sep, 2026

Anlon Healthcare informs about incorporation of subsidiary

Pursuant to regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’) read with SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 (‘SEBI Master Circular’), Anlon Healthcare has informed that ‘ANLON HEALTHCARE NIGERIA’ having Registration Number ‘9874492’ has been incorporated as a subsidiary of the Company, with effect from September 20, 2026. The relevant details pursuant to Schedule III of the Listing Regulations and additional details as required under the SEBI Master Circular for compliance with the provisions of the Listing Regulations by listed entities is annexed in Annexure - A.

The above information is a part of company’s filings submitted to BSE.

Sep, 2026

USFDA concludes inspection at Cohance Lifesciences’ Andhra Pradesh facility

The inspection concluded with the issuance of a Form FDA 483 containing five observations

Sep, 2026

Biocon informs about press release

Biocon has informed that it enclosed the press release titled ‘Biocon’s Pertuzumab Becomes First Biosimilar to Secure EMA CHMP Approval Recommendation Under New Tailored Clinical Approach’. The above information will also be available on the website of the Company at www.biocon.com.

The above information is a part of company’s filings submitted to BSE.

Sep, 2026

Concord Biotech informs about board meeting

Pursuant to Regulation 29(1) of Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015, Concord Biotech has informed that the meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, September 23, 2026 to consider the proposal for declaration of bonus equity shares to the existing equity shareholders of the Company in accordance with the applicable provisions, subject to approval of the shareholders of the Company. Pursuant to Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and Clause 9 of the Code for Prevention of Insider Trading in the securities of the Company, the company has informed that the Trading Window for dealing in the securities of the Company shall remain closed for all designated persons and their immediate relatives from today i.e. September 19, 2026 till 48 hours after the declaration of outcome of Board Meeting. The trading window shall be opened with effect from September 26, 2026.

The above information is a part of company’s filings submitted to BSE.

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Rank	Company	Market Capitalization 2026 (INR crores)
1	3B Blackbio Dx Ltd.	1,139 Crore
2	Aarti Drugs Ltd.	3,941 Crore
3	Aarti Pharmalabs Ltd.	7,443 Crore
4	Abbott India Ltd.	57,954 Crore
5	Acutaas Chemicals Ltd.	28,149 Crore
6	Advanced Enzyme Technologies Ltd.	3,227 Crore
7	Ajanta Pharma Ltd.	44,562 Crore
8	Akums Drugs & Pharmaceuticals Ltd.	12,339 Crore
9	Alembic Pharmaceuticals Ltd.	16,623 Crore
10	Alivus Life Sciences Ltd.	17,570 Crore

Do you know? Asking 3 Right Questions minimizes the RISK of Stock Investing To Know

Right Stock | Right Price | Right Allocation

Find best stocks to buy now Find best pharma stocks to buy now

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Abbott India Ltd. (M)	Very Good	27,170	57,954	35.89	11.20	24.65	34.24
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,950	1,82,738	83.79	20.36	38.34	29.04
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,461	67,169	37.36	6.13	12.46	27.89
Lupin Ltd. (M)	Somewhat Good	2,126	98,070	17.74	4.12	9.82	26.43
Ajanta Pharma Ltd. (M)	Very Good	3,505	44,562	39.27	9.17	26.53	25.35

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
Laurus Labs Ltd. (M)	Very Good	2,023	1,05,645	117
Sai Life Sciences Ltd. (S)	Somewhat Good	1,607	34,003	76.91
Aurobindo Pharma Ltd. (M)	Very Good	1,702	99,828	53.55
Divis Laboratories Ltd. (L)	Very Good	9,414	2,48,664	52.16
Gland Pharma Ltd. (M)	Very Good	2,935	48,875	45.50
				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
Sai Life Sciences Ltd. (S)	Somewhat Good	1,607	34,003	94.00	13.32	48.48	23.61
Mankind Pharma Ltd. (M)	Very Good	2,463	95,744	46.87	5.69	24.40	18.10
Ajanta Pharma Ltd. (M)	Very Good	3,505	44,562	39.27	9.17	26.53	13.54
Zydus Lifesciences Ltd. (M)	Very Good	1,171	1,15,012	25.48	4.27	14.28	13.52
Gland Pharma Ltd. (M)	Very Good	2,935	48,875	43.30	4.60	22.09	13.18

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Sai Life Sciences Ltd. (S)	Somewhat Good	1,607	34,003	94.00	13.32	48.48	39.96
Lupin Ltd. (M)	Somewhat Good	2,126	98,070	17.74	4.12	9.82	32.37
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,461	67,169	37.36	6.13	12.46	22.19
Abbott India Ltd. (M)	Very Good	27,170	57,954	35.89	11.20	24.65	17.33
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,215	97,749	30.34	2.56	15.56	15.75

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Top Pharma Companies in India by Market Cap

News about Top Pharma Companies in India

Anlon Healthcare incorporates subsidiary in Nigeria

Cohance Lifesciences informs about update

Anlon Healthcare informs about incorporation of subsidiary

USFDA concludes inspection at Cohance Lifesciences’ Andhra Pradesh facility

Biocon informs about press release

Concord Biotech informs about board meeting

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

How to select the top Nifty Pharma stocks based on RoE?

What are the best-performing stocks in the Nifty Pharma index?

Which Nifty Pharma stocks have the highest revenue growth in the past five years?

Which Nifty Pharma stocks had the highest profit growth in the past five years ?